Own report: Corona delta variant of the Indian corona vaccine covacin efficacy is not 6.8 percent, only 50 percent, this information caused a stir. This is according to a recent study by the All India Institute of Medical Sciences (AIIMS). The results of the study, which took place between April 15 and May 15, were also published in the Lancet Journal.
On the other hand, the effectiveness of Pfizer-Biotech vaccine is 93.8% to 6%. On the other hand, the effectiveness of AstraZeneca vaccine is 75% to 8%. Incidentally, the estimated efficacy of covacin in the third stage clinical trial was about 75%. The research report further states that covacin has this level of effectiveness in preventing corona up to 6 weeks after completion of the vaccine dose.
However, the study did not provide any information on the effectiveness of covacin in reducing the risk of serious illness and death after coronary heart disease. Covacin was developed simultaneously by the Indian Council of Medical Research and the National Institute of Virology, Pune.
Incidentally, the corona-graph of the downward country. Lotus daily death and infection. According to the statistics of the Union Ministry of Health on Thursday, 9,119 people have been infected with corona in the last 24 hours in the country. The number of daily victims was 9,263 yesterday. Some experts say India is fighting a corona war using vaccination as a tool. According to the Ministry of Health, more than 132 crore vaccine doses have been handed over to the states and union territories so far. More than 119 crore people have already received one dose of Corona Ticker.